Sign in

CIK 0001655759

  • Accelerated filer

ARVINAS, INC.

Sign in to watch
Ticker
ARVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472566120
Phone
+1 203-535-1456
Business address
395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, 06511
Former names
ARVINAS INC., ARVINAS HOLDING COMPANY, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,475
in 1 filing, $1K under 10b5-1 plans

Net −$1,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Loomis David K −$1K VP, Chief Accounting Officer sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2018-10-01 Margus Bradley Albert Director Conversion · Series C Preferred Stock −18,942 0
2018-10-01 Cassidy Sean A Chief Financial Officer Purchase +1,600 $16.00 $26K 169,465
2018-10-01 Cassidy Sean A Chief Financial Officer Conversion +5,345 174,810
2018-10-01 Cassidy Sean A Chief Financial Officer Conversion · Series B Preferred Stock −15,007 0
2018-10-01 Cassidy Sean A Chief Financial Officer Conversion · Series C Preferred Stock −2,368 0
2018-10-01 Loven Jakob Director Purchase +312,500 $16.00 $5.0M 312,500
2018-10-01 Loven Jakob Director Conversion +1,381,851 1,694,351
2018-10-01 Loven Jakob Director Conversion · Series C Preferred Stock −4,491,018 0
2018-10-01 Flynn James E 10% owner Conversion +307,078 307,078
2018-10-01 Flynn James E 10% owner Conversion +307,078 307,078
2018-10-01 Flynn James E 10% owner Conversion +307,078 307,078
2018-10-01 Flynn James E 10% owner Purchase +104,167 $16.00 $1.7M 411,245
2018-10-01 Flynn James E 10% owner Purchase +104,167 $16.00 $1.7M 411,245
2018-10-01 Flynn James E 10% owner Purchase +104,166 $16.00 $1.7M 411,244
2018-10-01 Flynn James E 10% owner Conversion · Series C Preferred Stock −998,004 0
2018-10-01 Flynn James E 10% owner Conversion · Series C Preferred Stock −998,004 0
2018-10-01 Flynn James E 10% owner Conversion · Series C Preferred Stock −998,004 0
2018-09-26 Kennedy Edward Moore Jr. Director Grant or award · Stock Option (right to buy) +32,870 32,870
2018-09-26 Taylor Ian Senior Vice President, Biology Grant or award · Stock Option (right to buy) +23,390 23,390
2018-09-26 Taylor Ian Senior Vice President, Biology Grant or award · Stock Option (right to buy) +2,600 2,600

Page 30 of 32 · 628 trades